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Seven couples underwent combined electroejaculation 
and in vitro fertilization for anejaculatory infertility after 
a failed regimen of  electroejaculation and intrauterine 
insemination. Two pregnancies resulted, one proceeding 
to a term vaginal delivery and one ending in a 6-week 
spontaneous abortion. Poor sperm binding and no fertil- 
ization were seen in two of  the couples. Fertilization of 
the oocytes but no subsequent pregnancy were seen in the 
other three couples. Combined in vitro fertilization and 
gamete intrafallopian transfer was performed in four of  
the couples. The combination of  electroejaculation and in 
vitro fertilization offers the opportunity to evaluate the 
female pelvis, observe the sperm-oocyte interaction, and 
achieve a pregnancy in couples with anejaculatory infer- 
tility. 
KEY WORDS: electroejaculation; anejaculation; in vitro fertil- 
ization. 
INTRODUCTION 
Male-factor infertility as a result of anejaculation 
may occur following spinal cord injury or retroperi- 
toneal surgery or as a result of multiple sclerosis, 
diabetes mellitus, or psychogenic causes. Electro- 
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ejaculation facilitates the collection of sperm, per- 
mitting processing and insemination and resulting in 
successful pregnancies (1) in this previously infer- 
tile group of patients. 
Two critical factors in the success of electroejac- 
ulatiordinsemination are the evaluation of the fe- 
male partner and subsequent timing of insemina- 
tions. The evaluation of the female ultimately in- 
cludes a diagnostic laparoscopy to rule out pelvic 
factors for infertility. In addition to visualizing the 
pelvis, laparoscopy provides an opportunity for 
oocyte retrieval, gamete intrafallopian transfer 
(GIFT), and in vitro fertilization (IVF) to assess the 
capacity of sperm obtained by electroejaculation to 
penetrate the spouse's oocytes. This paper presents 
the first seven couples undergoing combined elec- 
troejaculation and IVF/GIFT in the Electroejacula- 
tion/Insemination Program at the University of 
Michigan from December 1986 through November 
1988. 
MATERIALS AND METHODS 
Patients.  Anejaculatory males were referred to 
the Section of Urology, Department of Surgery, at 
the University of Michigan Medical Center for eval- 
uation and possible electroejaculation. The cause of 
anejaculation was spinal cord injury in six men and 
radical retroperi toneal  lymph node dissection 
(RPLND) for testicular carcinoma in the remaining 
patient. The period of anejaculation ranged from 2 
to 19 years. 
After preliminary male evaluation, all female 
partners were evaluated by the Division of Repro- 
ductive Endocrinology and Infertility, Department 
of Obstetrics and Gynecology, at the University of 
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Michigan Medical Center. All were in good health 
without significant medical problems. One patient 
was previously noted to have a normal pelvis at the 
time of diagnostic laparoscopy to rule out suspected 
endometriosis. A second patient had undergone a 
right salpingostomy for an ampullary ectopic preg- 
nancy but demonstrated bilateral tubal patency on 
subsequent hysterosalpingography. None of the 
other patients had any risk factors for tubal infertil- 
ity. 
The males ranged from 28 to 37 years of age, 
whereas the females ranged from 24 to 37 years of 
age at the time of the stimulation cycle. Four of the 
patients were nulligravidas, with only patient 6 hav- 
ing successfully carried a child in the past. 
Program Protocol. The Elect roejacula t ion/  
Insemination Program is divided into an initial eval- 
uation phase, a second insemination phase, and a 
third IVF phase. The initial phase consists of the 
evaluation of the male and a variable number of 
preliminary electroejaculation procedures to estab- 
lish the optimal stimulation and appropriate re- 
sponse. The female partner was evaluated just prior 
to entry into the second phase of the Program. 
Male partners received 1.5 g sodium bicarbonate 
orally at 12 AM on the night prior to electroejacula- 
tion and again 1 hr before the procedure to achieve 
a urine pH of 7-8 at the time of the procedure. If the 
patient had a high spinal cord injury, and it was 
deemed autonomic dysreflexia would be a risk, 20 
mg sublingual nifedipine was given for prophylaxis. 
Patients with incomplete spinal cord lesions were 
given midazolam for sedation. The RPLND patient 
had normal sensation and required general anesthe- 
sia for the electroejaculation procedure. Immedi- 
ately preceding electroejaculation a catheterized 
urine specimen was tested for acidity and the blad- 
der was washed with intrauterine insemination 
(IUI) medium [Hamm's F-10 (Gibco No. 430-1200), 
Hepes buffer, 20 mM (Sigma No. H3375), and 1% 
human serum albumin (Fraction V, 96-99% pure, 
Cutter 685-20)] if the pH was less than 7.0. A Model 
10 electroejaculator probe (G and S Instrument Co., 
M-10) was inserted 6-8 in. into the anal canal with 
the patient in the lateral decubitus position. Pro- 
gressively increasing voltage was delivered in a 
wavelike pattern until ejaculation was achieved. 
Stimulation was initiated at 2-3 V, with each sub- 
sequent stimulation occurring 6--8 sec later with an 
increase in voltage of I V. Blood pressure was mon- 
itored throughout the procedure, which utilized an 
average of 19 V and 450 amp. The antegrade sperm 
were collected by milking the phallus. After the pro- 
cedure the bladder was catheterized to collect the 
retrograde ejaculate. Five to ten ml of IUI medium 
was utilized to flush the bladder to obtain any re- 
sidual ejaculate. 
Both antegrade and retrograde samples were 
washed with IUI medium, followed by a "swim- 
up"  for 1 hr. The supernatant containing motile 
spermatozoa was removed and centrifuged for 6 
min at 400g. The pellet was resuspended in IUI me- 
dium and a count, percentage motility, and forward 
progression were determined. A second centrifuga- 
tion was performed, with the resulting pellet resus- 
pended in 250 ~1 of IUI medium. The second sam- 
ple in couple 2 was swum-up from IUI medium con- 
taining 5% human serum albumin and all three 
oocytes  collectively inseminated with 5 x 105 
sperm. 
The evaluation of the female partner included an 
initial history and physical examination, the record- 
ing of basal body temperatures, and a hysterosal- 
pingogram to document bilateral tubal patency. For 
the insemination phase of the program, all female 
patients were placed on clomiphene citrate, 50 mg/ 
day, on days 5-9 of each cycle to assure predictable 
timing for subsequent electroejaculation/insemina- 
tion procedures. Patients were seen on the day be- 
fore expected ovulation, at which time transvaginal 
ultrasonography was performed to document the 
presence of a preovulatory follicle. Human chori- 
onic gonadotropin (hCG), 10,000 U, was adminis- 
tered im if the follicle was greater than or equal to 
17 mm in mean diameter. The male partner under- 
went electroejaculation on the day of hCG and on 
the following day, with subsequent sperm process- 
ing and intrauterine insemination each day. 
All couples had undergone at least six cycles of 
electroejaculation/insemination without pregnancy 
before proceeding to the third phase of the pro- 
gram. One couple had undergone five of six at- 
tempts at a different program. The first four women 
underwent a superovulation protocol consisting of 
225 U of human menopausal gonadotropins (hMG) 
daily beginning on day 3 of the menstrual cycle. 
Vaginal ultrasonography and serum testing for es- 
tradiol and progesterone concentrations were begun 
on day 5 of the cycle, with repeat studies every 
24 48 hr. The last three patients in the series began 
leuprolide on day 21 of the cycle preceding the IVF 
cycle and began 225 U of hMG daily 10 days after 
beginning leuprolide therapy. Monitoring of these 
patients was identical to that of the first four pa- 
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tients in the series. When at least two follicles were 
greater than or equal to 16 mm in mean diameter 
and the estradiol level was greater than or equal to 
500 pg/ml, 10,000 U hCG was administered im and 
the laparoscopy scheduled for 36 hr later. 
Electroejaculation was performed several hours 
prior to scheduled laparoscopy to allow for sperm 
processing. Laparoscopy was carried out under 
general anesthesia, with all patients demonstrating 
normal anatomy. Follicular aspiration was per- 
formed in a standard fashion and GIFT performed 
with a maximum of four oocytes if the processed 
sperm were deemed appropriate. The GIFT proce- 
dures utilized a Marrs catheter (Cook Ob/Gyn, 
Spencer, IN) loaded with 5 p~l medium, 1.25 x 105 
sperm in 25 ~1 medium, 1-2 oocytes in 20 ixl me- 
dium containing 7.5% female serum, 1 txl air, and I 
~1 medium. Oocytes were equilibrated and insemi- 
nated with 1.0 x 105 to 2.5 • 105 sperm per dish 4--6 
hr after retrieval. Sperm binding was assessed later 
that day and, in one patient, deemed to be unac- 
ceptable; therefore, a second ejaculation was per- 
formed that day with reinsemination of the oocytes. 
The oocytes were evaluated the following morning 
and repeat ejaculation and reinsemination were per- 
formed if fertilization failed as in two of the pa- 
tients. Embryo transfer was carried out 44-48 hr 
after oocyte retrieval. Patients on the hMG stimu- 
lation protocol received progesterone supposito- 
ries, 100 mg bid, beginning on the day after embryo 
transfer, whereas the patients receiving leuprolide/ 
hMG began progesterone, 25 mg im daily, on the 
day following oocyte retrieval. Two weeks after 
oocyte retrieval a quantitative serum beta hCG 
level was obtained. If it was positive, the patient 
was maintained on progesterone; if it was negative, 
progesterone was discontinued and menses ensued. 
RESULTS 
The results are listed in Table I. Two of the seven 
couples conceived, with one pregnancy progressing 
to a term singleton delivery and the second ending 
in a spontaneous abortion at 6 weeks of gestation as 
evidenced by the passage of gestational tissue. 
Chromosomal analysis of the aborted tissue was not 
obtained. The number of eggs obtained ranged from 
3 to 12, with all eggs in excess of 6 frozen for pos- 
sible future use. 
Initial sperm counts ranged from 0. I x 10 6 to 40 
• 106/ml, with a range of motility from 1 to 75%. 
Sperm binding and fertilization were noted in five of 
the seven couples, with all of the couples demon- 
strating some progression of fertilized oocytes to 
cell cleavage. 
Table I. Couples Undergoing IVF/GIFT After Electroejaculation, December 1986 Through November 1988 
No. No. No. % 
Pt Female Peak day eggs fertil- trans- Out- Male Time Count motil- 
No. age G-P Rx E2 hCG (frozen) GIFT ized ferred come age Level (years) (• ity 
1 24 G1P0 hMG 1089 10 8 
2 25 GO hMG 965 8 3 
3 36 GO hMG 1565 7 8 (2) 
4 31 GO hMG 545 9 6 
5 37 GO Lupron/ 
hMG 1584 13 9 (3) 
6 35 G2PI Luprord 
hMG 1857 12 12 (6) 
7 29 G1P0 Lupron/ 















0 0 ( - ) 29 T6 2 40.0 45 
3 3 (+)4 28 T12-L1 4 (1) 0.1 1 
(2) 1.0 25-30 
2 2 ( - )  37 C5-C6 19 10.0 50 
2 2 ( + )b 32 T10-T11 5 6.0 80 
0 0 (-) 37 T7 14 (1) 1.4 20-25 
(2) 0.2 25 
2 2 (-) 31 RPLND 4 14 75 
No 5 5 ( - )  33 T5-T6 5 (1) 8.0 5 
(2) 0.6 65 
a Term birth. 
b Six-week SAb. 
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No fertilization was seen in two of the seven cou- 
ples. In Couple 1, despite an initial count of 40 • 10 6 
sperm/ml with 45% motility, no binding of sperm to 
the oocyte was seen. Subsequent testing failed to 
reveal the presence of antisperm antibodies or 
mouse embryo toxicity in the female's serum. In 
Couple 5, poor sperm counts and motility were 
noted in two ejaculates with minimal binding and no 
fertilization. Couple 2 demonstrated a very poor 
count and motility in the sample obtained on the 
day of retrieval with an improved but still abnormal 
sample obtained the following day. The second 
sample successfully fertilized all three oocytes ob- 
tained and the subsequent embryo transfer resulted 
in a term singleton delivery. 
DISCUSSION 
Couples with anejaculatory infertility present a 
frustrating subgroup of patients with male-factor in- 
fertility. The effect of extended anejaculation on 
sperm production and function has not yet been 
well characterized. Moreover, the problem causing 
the anejaculation may result in other complications 
directly or indirectly affecting sperm quality such as 
chronic urinary tract infections in patients with spi- 
nal cord injuries. 
Electroejaculation is now a clinically acceptable 
method for obtaining semen from men with chronic 
anejaculation (2). Since the first reports of success- 
ful conception with sperm obtained by electroejac- 
ulation (3,4), the combination of electroejaculation 
and intrauterine insemination has resulted in preg- 
nancies in couples with the male having suffered a 
spinal cord injury (1), with multiple sclerosis (5), 
after a retroperitoneal lymph node dissection for 
testicular carcinoma (6), and with psychogenic an- 
ejaculation (7). 
A critical part of the success with electroejacula- 
tion has involved an appropriate evaluation of the 
female partner, appropriate timing of the electro- 
ejaculation and insemination, and the use of intra- 
uterine insemination of processed sperm. In the 
Electroejaculation/Insemination Program at the 
University of Michigan, all female partners were 
evaluated for risk factors for infertility, for tubal 
patency, and for regular ovulation. Due to the dis- 
tances many couples traveled to participate in the 
program and ensure predictable follicular develop- 
ment, all women were placed on clomiphene citrate 
and received hCG to assure ovulation at a time ap- 
propriate for insemination. Since all of the women 
had bilateral tubal patency and no other major risk 
factors for tubal infertility, a surgical evaluation 
was deferred until after a trial of electroejaculation 
and intrauterine insemination. When it was felt that 
conception had not occurred despite an adequate 
trial, the couples were offered the opportunity for 
IVF at the time of recommended laparoscopy. It 
was felt that little if any morbidity would be added 
to the procedure, that the quality of the sperm ob- 
tained at electroejaculation could be better as- 
sessed, and that a pregnancy might ensue. The use 
of IVF for male-factor infertility has been well de- 
scribed (8) and offers a viable alternative to couples 
with poor sperm numbers or quality. In some cou- 
ples, the presence or absence of in vitro fertilization 
of the woman's oocytes by the man's sperm may be 
the deciding factor in determining whether to pur- 
sue other methods with which to become pregnant, 
such as donor insemination, or whether to pursue 
adoption or a childless life-style. 
Only one of the seven female partners had carried 
a child to term before, with four of the women being 
nulligravid at the time of the IVF cycle. Both preg- 
nancies established were in previously nulligravid 
patients. 
Over the 2-year span of the series, the IVF pro- 
tocol was modified. During the course of this series, 
embryo freezing was not available, although oocyte 
freezing was routinely performed rather than dis- 
carding excess oocytes that were not inseminated. 
Patient 3 had two oocytes frozen, with one ulti- 
mately surviving the freezing process, becoming 
fertilized, and being transferred to the woman in an 
unstimulated cycle without a subsequent concep- 
tion. 
Final sperm counts and motility varied widely 
among patients and were not reliable indicators of 
eventual fertilization. The highest count seen was in 
the couple where sperm binding was poor and no 
fertilization was noted. In contrast, the only term 
pregnancy reported resulted from a sample with a 
relatively low sperm concentration and decreased 
motility obtained in a repeat ejaculation the day fol- 
lowing laparoscopy and retrieval (9). IVF and GIFT 
were performed in four of the seven couples due to 
the reported improved pregnancy rates with GIFT 
but the need to observe the in vitro sperm-egg in- 
teraction. Of note, all of the women demonstrated 
apparently normal pelves. 
The number of patients in this series is too small 
to establish reliable success rates with this com~ 
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bined technique, but the occurrence of two preg- 
nancies with one term delivery certainly demon- 
strates the potential of the technique. By demon- 
strating the fertilization of retrieved human oo- 
cytes, the technique provides a valuable in vitro 
assessment of the functional capacity of sperm ob- 
tained by electroejaculation. 
CONCLUSIONS 
In summary, this report describes the initial ex- 
perience with electroejaculation and in vitro fertil- 
ization in an anejaculatory subset of couples with 
male-factor infertility and establishes this combined 
technique as a viable approach to the treatment of 
couples with a particularly frustrating type of infer- 
tility. 
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